Project Grant 2507798
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$305K
Federal Agency
National Science Foundation
Awardee
Gelastomerics LLC (D8DGGC3K1618)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Fort Collins, CO 80526, USA
Similar Awards
This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a sustainable solution for upcycling waste plastics into high-value thermoplastic elastomers for infrastructure applications. The $274,991 award to Molten Materials LLC, a woman-owned small business in Santa Ana, CA, will explore the use of reversible addition-fragmentation chain transfer (RAFT) polymerization to produce...
This National Science Foundation (NSF) Cooperative Agreement award, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a novel sprayable hydrogel sealant for managing gastrointestinal lesions and bleeding. The $1,250,000 project, awarded to Biodevek Inc., a small business in Boston, MA, focuses on advancing the technical development of a hydrogel delivery system that can be seamlessly integrated with endoscopic procedures. Key objectives...
The National Science Foundation (NSF) awarded a $1,000,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Impressio Inc., a for-profit manufacturer headquartered in Thornton, Colorado. The award supports the development, verification, validation, and commercialization of a liquid-crystal elastomer (LCE)-based cartilage replacement device to treat hallux rigidus, a joint disorder affecting the base of the big toe. The project aims to...
This SBIR Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop a scalable manufacturing process for a novel spinal implant technology based on supramolecular polymers. The primary objectives are to: 1) manufacture the active supramolecular polymer ingredient at large scales suitable for clinical use, and 2) combine this with other materials to...
Karios Technologies LLC, a for-profit organization, received a $274,954 SBIR Phase I grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel, ready-to-use, large volume delivery system for in situ forming biomaterials. The biomaterials are intended to serve as tissue sealants, scar tissue reducers, and vehicles for drug or cell delivery during surgical procedures. The project aims to transfer a proprietary biomaterial...
The National Science Foundation (NSF) awarded a $273,563 Small Business Innovation Research (SBIR) Phase I grant to Medicarbone Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The objective of this 12-month project is to design, develop, and demonstrate the feasibility of a minimally-invasive intramedullary (IM) sleeve system with an in situ, photocurable, and removable polymeric bone cement for the treatment of orthopedic fractures. The project aims to address...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) will fund the development of an advanced wound care product to treat diabetic foot ulcers. The $305,000 award to Therapeutic Bandage Products, Inc. will support the creation of a patented microneedle bandage that delivers a combination of therapeutic agents to disinfect wounds, prevent biofilm formation, and activate the immune system to promote...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I project, awarded under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), focuses on the development of a novel manufacturing approach for bioengineered, next-generation tympanostomy tubes using natural biopolymers such as silk and chitosan. The project aims to create degradable, biocompatible, and antimicrobial tympanostomy tubes that can eliminate the need for surgical removal,...
Acatechol, Inc. was awarded a $274,982 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant to develop an innovative anti-infective coating for Foley catheters. The project aims to create a hybrid coating that combines biofilm-repellent and antimicrobial properties to provide prolonged resistance against pathogen colonization and catheter-associated urinary tract infections (CAUTIs). This work is being conducted under the NSF Technology, Innovation, and...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I project aims to develop a novel, minimally invasive, bioabsorbable, steroid-eluting suture and surgical implant procedure to improve outcomes for 6 million patients suffering from rhinitis under the care of otolaryngologists. The $255,045 award, granted on September 15, 2023 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, will fund the formulation of dissolvable polymers,...